<DOC>
	<DOCNO>NCT00423176</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Nasonex® ( mometasone furoate nasal spray ) , use together antibiotic , relief symptom associate acute bacterial sinusitis . Efficacy base subjective ( assessment symptom severity patient ) objective measurement ( compute tomography [ CT ] image sinus ) .</brief_summary>
	<brief_title>The Study Nasonex® Compared With Placebo Relief Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics ( Study P04824AM3 )</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Must 12 year age old , either sex , race . Must weigh least 40 kg ( 88 lb ) . Must willing give write informed consent able adhere dose visit schedule . Must clinical diagnosis acute bacterial sinusitis . Must symptomatic Screening Baseline Visits basis subject assessment major symptom score . Must radiographic evidence sinusitis CT scan take Screening . Must general good health free clinically significant disease ( sinusitis ) would interfere study schedule procedure , compromise subject 's safety . A subject 's clinical laboratory test ( hematology , blood chemistry , urinalysis ) , vital sign , electrocardiogram ( ECG ) recording must within normal limit clinically acceptable investigator/qualified designee . Any test result questionable referred sponsor . A female subject childbearing potential must negative serum pregnancy ( betahCG ) test Screening . She must agree use medically accept method contraception throughout entire study period . Postmenopausal woman exempt use contraception study . Documented absence menses least 1 year indicate female postmenopausal . If premenarche female subject begin menstruate study , serum pregnancy test must do next visit . A female subject childbearing potential currently sexually active must agree use medically accept method contraception become sexually active participate study . A subject moderate severe persistent asthma require daily treatment inhaled steroid , exacerbation asthma within past 30 day . A history chronic sinusitis ( symptom last great 3 month ) undergo sinus nasal surgery chronic sinusitis nasal polyp . A history symptomatic seasonal allergic rhinitis , study period , live travel location allergen he/she allergic present . Subject glaucoma history posterior subcapsular cataract . Subject nasal polyp visible upon physical examination , immotile cilium syndrome , immunodeficiency disease , cystic fibrosis , clinically significant cardiovascular ( include rheumatic heart disease ) , pulmonary , renal , hepatic , metabolic , hematological neurologic disease investigator 's judgment might interfere evaluation therapy , subject immunocompromised , renal failure , dialysis . Subject fail observe medication washout time outline protocol prior Screening . Subject allergy corticosteroid penicillin . Subject use investigational drug within 30 day Screening . Subject concurrent need antibiotic therapy study drug ( amoxicillin/clavulanic acid ) . Subject anticipate sinus nasal surgery within next month . Subject previously randomize study . Subject part staff personnel directly involve study family member investigational study staff involve study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>